Hinge Health Reports 53% Revenue Growth to $212.8 Million in Latest Quarter

Hinge Health, Inc. reported significant financial growth in its latest quarterly filing for the period ending June 30, 2026. The company achieved revenue of $212.8 million, a 53% increase from $139.1 million in the same period last year. For the first half of 2026, revenue reached $395.1 million, up 50% from $262.9 million in the first half of 2025. The increase in revenue was primarily attributed to growth from existing clients, as the company continues to expand its client base and enhance member engagement.

The company's gross profit for the second quarter was $183.9 million, representing an 88% increase compared to $97.8 million in the prior year. This resulted in a gross margin of 86%, up from 70% in the same quarter of 2025. The reduction in cost of revenue, which fell by 30% to $28.9 million, was a key factor in this improvement, largely due to a significant decrease in stock-based compensation expenses related to prior vesting criteria achieved in connection with the company's IPO.

Hinge Health's operational metrics also showed positive trends, with the number of clients increasing to 2,929 as of June 30, 2026, up from 2,359 a year earlier. The company reported a total of 782,890 members, reflecting its growing penetration in the market. The average eligible lives, which represent the population that can access Hinge Health's services, reached 20.1 million, up from 15.7 million in the previous year. The company continues to focus on expanding its offerings, including the recent launch of its Migraine Care Program and plans for geographic expansion.

In terms of strategic developments, Hinge Health announced its intention to acquire Cylinder Health, Inc. for $105 million, which is expected to enhance its capabilities in virtual-first digestive health care. The acquisition is anticipated to close in the third quarter of 2026. Additionally, the company has been actively repurchasing its Class A common stock, with $196.5 million repurchased under its share repurchase program as of July 29, 2026. The board has authorized a total of $496.5 million for future repurchases, reflecting confidence in the company's financial position.

Looking ahead, Hinge Health remains optimistic about its growth trajectory, emphasizing its commitment to innovation and expanding its market presence. The company aims to leverage its AI-driven platform to enhance member outcomes and reduce costs for clients, while also navigating the challenges posed by macroeconomic conditions. The management's focus on client retention and expanding the number of enrolled members within existing clients is expected to drive future revenue growth.